TY - JOUR
T1 - Probiotics and immune regulation of inflammatory bowel diseases.
AU - Cong, Yingzi
AU - Konrad, Astrid
AU - Iqbal, Nuzhat
AU - Elson, Charles O.
PY - 2003/6
Y1 - 2003/6
N2 - Intestinal microflora play an important role in the pathogenesis of inflammatory bowel diseases (IBD). Certain probiotic bacteria provide beneficial effects for human health and intervention of IBD. Possible mechanisms underlying these effects are diverse and include many aspects of the interaction of the host with its commensal microflora, with immunological and non-immunological effects. This review paper will focus on the recent progress in the use of probiotics in the treatment of IBD, and discuss the potential immunological mechanisms underlying their effects, such as the modulation of mucosal T cell, B cell, epithelial cell, dendrtic cell, macrophage, nature killer cell, antibody, and cytokine responses.
AB - Intestinal microflora play an important role in the pathogenesis of inflammatory bowel diseases (IBD). Certain probiotic bacteria provide beneficial effects for human health and intervention of IBD. Possible mechanisms underlying these effects are diverse and include many aspects of the interaction of the host with its commensal microflora, with immunological and non-immunological effects. This review paper will focus on the recent progress in the use of probiotics in the treatment of IBD, and discuss the potential immunological mechanisms underlying their effects, such as the modulation of mucosal T cell, B cell, epithelial cell, dendrtic cell, macrophage, nature killer cell, antibody, and cytokine responses.
UR - http://www.scopus.com/inward/record.url?scp=0642375565&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0642375565&partnerID=8YFLogxK
U2 - 10.2174/1568010033484278
DO - 10.2174/1568010033484278
M3 - Review article
C2 - 14561167
AN - SCOPUS:0642375565
SN - 1568-010X
VL - 2
SP - 145
EP - 154
JO - Current drug targets. Inflammation and allergy
JF - Current drug targets. Inflammation and allergy
IS - 2
ER -